Ras inhibitors
Ras inhibitors has been studied in 3 papers since 2024: 1 observational study in people, 2 reviews; 2 in the past year. The newest paper, Oct 26, 2026: “Temporal trends in incident heart failure medication use and clinical characteristics across guideline eras: a retrospective cohort study”.
3 papers study it2 findingsUpdated
1 new paper in 30 daysSee all 3 papers on ras inhibitors
- Humans1
What did studies of ras inhibitors find?
1Studies of ras inhibitors measured one outcome, chronic kidney disease.
Chronic kidney disease
downin humans1
1 study
Chronic kidney disease
downin humans1
Ras inhibitors decrease chronic kidney disease in four-pillar pharmacotherapy.
“When tailored to the degree of albuminuria and eGFR, this treatment significantly slows the progression of chronic kidney disease and reduces cardiovascular risk.”
Reviewin four-pillar pharmacotherapykidney
Albuminuria for detection of chronic kidney disease: biomarker and therapeutic target
Orvosi hetilap
What is ras inhibitors linked with?
1Studies link ras inhibitors with muscle strength.
Muscle strength
mixedin reviews1
1 study
Muscle strength
mixedin reviews1
Ras inhibitors are associated with muscle strength.
“effects of the use of RAS inhibitors on muscle strength”
Review
Muscle mass, muscle strength and the renin-angiotensin system
Clinical science (London, England : 1979)